Cap­tured in a harsh spot­light, biotech uni­corn Mod­er­na names Melis­sa Moore as its new CSO

As Mod­er­na Ther­a­peu­tics drew a harsh re­view from Stat, por­trayed as a com­pa­ny in tur­moil with an of­ten em­bit­tered staff, the biotech uni­corn named …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.